We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$11.2M
2
XOM icon
ExxonMobil
XOM
+$10.8M
3
AAPL icon
Apple
AAPL
+$10.8M
4
IBB icon
iShares Biotechnology ETF
IBB
+$10.2M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.12M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$265M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$98.3M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$32.7M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$18.2M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.9M

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HELE icon
1876
Helen of Troy
HELE
$693M
$27K ﹤0.01%
321
-321
-50% -$26.9K
IBRX icon
1877
ImmunityBio
IBRX
$7.99B
$27K ﹤0.01%
4,593
+4,540
+8,566% +$30.3K
INO icon
1878
Inovio Pharmaceuticals
INO
$67.8M
$27K ﹤0.01%
326
+284
+676% +$25.7K
OPLN
1879
Openlane
OPLN
$4.56B
$27K ﹤0.01%
1,638
+930
+131% +$14.8K
MLR icon
1880
Miller Industries
MLR
$626M
$27K ﹤0.01%
1,003
+898
+855% +$21.9K
NERV icon
1881
Minerva Neurosciences
NERV
$196M
$27K ﹤0.01%
+285
New +$29.1K
NNN icon
1882
NNN REIT
NNN
$8.98B
$27K ﹤0.01%
608
-12,730
-95% -$562K
NPK icon
1883
National Presto Industries
NPK
$987M
$27K ﹤0.01%
256
+176
+220% +$16.4K
NTLA icon
1884
Intellia Therapeutics
NTLA
$1.67B
$27K ﹤0.01%
2,046
-1,986
-49% -$29.8K
NVS icon
1885
Novartis
NVS
$298B
$27K ﹤0.01%
408
+6
+1% +$389
RRX icon
1886
Regal Rexnord
RRX
$12B
$27K ﹤0.01%
393
-707
-64% -$46.8K
STRA icon
1887
Strategic Education
STRA
$1.92B
$27K ﹤0.01%
337
+137
+69% +$8.95K
SWBI icon
1888
Smith & Wesson
SWBI
$642M
$27K ﹤0.01%
1,683
+1,518
+920% +$28K
TRAK icon
1889
ReposiTrak
TRAK
$158M
$27K ﹤0.01%
+2,129
New +$28.9K
TV icon
1890
Televisa
TV
$1.5B
$27K ﹤0.01%
1,284
-451
-26% -$10.4K
TVTX icon
1891
Travere Therapeutics
TVTX
$5.8B
$27K ﹤0.01%
1,426
+487
+52% +$9.96K
SUM
1892
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$27K ﹤0.01%
1,182
-717
-38% -$15K
VIRX
1893
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$27K ﹤0.01%
+214
New +$29.8K
COR
1894
DELISTED
Coresite Realty Corporation
COR
$27K ﹤0.01%
335
+235
+235% +$17.3K
GLOG
1895
DELISTED
GASLOG LTD
GLOG
$27K ﹤0.01%
1,701
+1,695
+28,250% +$27K
RRTS
1896
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$27K ﹤0.01%
+105
New +$24.3K
GHDX
1897
DELISTED
Genomic Health, Inc.
GHDX
$27K ﹤0.01%
907
+160
+21% +$4.88K
BEL
1898
DELISTED
Belmond Ltd.
BEL
$27K ﹤0.01%
+2,042
New +$26.2K
ITG
1899
DELISTED
Investment Technology Group Inc
ITG
$27K ﹤0.01%
+1,375
New +$24.9K
AFAM
1900
DELISTED
Almost Family Inc
AFAM
$27K ﹤0.01%
+603
New +$24.6K
74 75
76
77 78

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.